Entity

Time filter

Source Type

Novato, CA, United States

An enteric-coated bead dosage form of cysteamine, and related methods of manufacture and use, are disclosed.


An enteric-coated bead dosage form of cysteamine, and related methods of manufacture and use, are disclosed.


An enteric-coated bead dosage form of cysteamine, and related methods of manufacture and use, are disclosed.


The present invention is directed to a methods and compositions for receptor mediated drug delivery, particularly across the blood-brain barrier.


Patent
Raptor Pharmaceuticals | Date: 2014-11-06

The present disclosure is directed to methods for treating inherited or acquired mitochondrial disease using a cysteamine product, e.g., cysteamine or cystamine or derivatives thereof.

Discover hidden collaborations